The risks of autoimmune inflammatory outcomes in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study

By sjmartinez • March 13, 2025

Zhang L, Chen D, Long Y, Li L, Lyu Y, Meng M, Ma Y, Wu Y, Leung FW, Sha W, Chen H, Liu Y. The risks of autoimmune inflammatory outcomes in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study. Int J Surg. 2025 Mar 12. doi: 10.1097/JS9.0000000000002333. Epub ahead of print. PMID: 40072357.

Tags: Digestive Diseases, Publications, Veterans Administration

IL-23p19 Antagonists vs. Ustekinumab for Treatment of Crohn’s Disease: A Meta-analysis of Randomized Controlled Trials

Dziegielewski C, Yuan Y, Ma C, Boland BS, Chang JT, Syal G, Vuyyuru SK, Peyrin-Biroulet L, Jairath V, Singh S. IL-23p19 Antagonists vs. Ustekinumab for[...]

Secondary SBP Prophylaxis is associated with a higher rate of non-SBP infections in Two US-based National Cirrhosis Cohorts

Silvey S, Patel N, O'Leary JG, Jakab SS, Patton H, Rogal S, Markley JD, Cheung R, Patel A, Morgan TR, Bajaj JS. Secondary SBP Prophylaxis[...]

Sex-dependent alterations of colonic epithelial permeability: relevance to irritable bowel syndrome

Larauche M, Mahurkar-Joshi S, Biraud M, Ju T, Mayer EA, Chang L. Sex-dependent alterations of colonic epithelial permeability: relevance to irritable bowel syndrome. Front Physiol.[...]